Page last updated: 2024-08-18

lactobionic acid and Disease Models, Animal

lactobionic acid has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Anfuso, CD; Cristaldi, M; Gagliano, C; Genovese, C; Lupo, G; Olivieri, M; Pezzino, S; Rusciano, D1
Elias, PM; Fujiwara, S; Hatano, Y; Jeong, SK; Matsuda-Hirose, H; Sakai, T; Takahashi, D; Zhang, W1

Other Studies

3 other study(ies) available for lactobionic acid and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Experimental Evidence of the Healing Properties of Lactobionic Acid for Ocular Surface Disease.
    Cornea, 2018, Volume: 37, Issue:8

    Topics: Animals; Cell Count; Cell Line; Cornea; Corneal Diseases; Disaccharides; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Rabbits; Wound Healing

2018
Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine Atopic Dermatitis.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:2

    Topics: Animals; Dermatitis, Atopic; Disaccharides; Disease Models, Animal; Drug Therapy, Combination; Epidermis; Immunoglobulins; Mice; Mice, Inbred Strains; Oxazolone; Random Allocation; Receptor, PAR-2; Receptors, Cytokine; Treatment Outcome

2016